Valeria F Caparbo
Overview
Explore the profile of Valeria F Caparbo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
527
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franco A, Murai I, Yang T, Takayama L, Bonoldi V, Caparbo V, et al.
Semin Arthritis Rheum
. 2025 Feb;
71:152644.
PMID: 39899916
Background: Sjögren's disease (SjD) arthritis is non-erosive, but joint involvement in this disease remains unclear. This study investigated the association between bone erosions and clinical parameters using high-resolution peripheral quantitative...
2.
Rocha G, Santos J, Sales L, Franco A, Caparbo V, Takayama L, et al.
Int J Rheum Dis
. 2024 Dec;
27(12):e15434.
PMID: 39628110
Aims: Gout, a prevalent inflammatory arthropathy, predominantly affects males and arises from persistent hyperuricemia, resulting in monosodium urate crystal deposition. Hyperuricemia is associated with comorbidities, exacerbating patient morbidity. Conflicting literature...
3.
Furquim M, Hounkpe B, Caparbo V, Giardini H, S V Barbas C, Domiciano D, et al.
BMC Rheumatol
. 2024 Nov;
8(1):63.
PMID: 39568080
Background: Chronic invasive rhinosinusitis with facial bone damage is a common cause of functional and social impairment in granulomatosis with polyangiitis (GPA) patients. To the best of our knowledge, there...
4.
Valente G, Machado L, Figueiredo C, Caparbo V, Takayama L, Franco A, et al.
Bone
. 2024 Nov;
190:117308.
PMID: 39486600
While visceral fat measured by dual-energy X-ray absorptiometry (DXA) is accurate in identifying middle-aged people at increased cardiometabolic risk, consistent data for the elderly are still lacking. We aimed to...
5.
Sales L, Souza L, Fernandes A, Murai I, Santos M, Vendramini M, et al.
Clinics (Sao Paulo)
. 2024 Aug;
79:100474.
PMID: 39208655
Objective: To investigate the effect of a single oral dose of 200,000 IU of vitamin D on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19. Methods: This is...
6.
Hounkpe B, Sales L, Ribeiro S, Perez M, Caparbo V, Domiciano D, et al.
Front Immunol
. 2024 Jun;
15:1400036.
PMID: 38835762
Introduction: Polyarticular juvenile idiopathic arthritis (pJIA) is a childhood-onset autoimmune disease. Immune cells contribute to persistent inflammation observed in pJIA. Despite the crucial role of monocytes in arthritis, the precise...
7.
Silva F, Machado G, Ribeiro A, Bonfiglioli K, Shimabuco A, Figueiredo C, et al.
Osteoporos Int
. 2024 Jan;
35(5):819-830.
PMID: 38267666
Purpose: To assess risk factors for fractures, including clinical, laboratory and dual energy X-ray absorptiometry (DXA) parameters (bone mass, trabecular bone score-TBS, muscle mass) in women with established rheumatoid arthritis...
8.
Ribeiro S, Sales L, Fernandes A, Perez M, Takayama L, Caparbo V, et al.
Semin Arthritis Rheum
. 2023 Aug;
63:152247.
PMID: 37595510
Objectives: To analyze longstanding polyarticular juvenile idiopathic arthritis (pJIA) for possible associations between localized bone damage (erosions), and systemic bone loss. Besides, to compare the systemic bone mass of pJIA...
9.
Franco A, Murai I, Takayama L, Caparbo V, Marchi L, Velloso E, et al.
Calcif Tissue Int
. 2023 Jun;
113(3):276-285.
PMID: 37294314
Patients with systemic mastocytosis (SM) are at high risk of bone deterioration. However, the evaluation of bone microarchitecture in this disease remains unclear. We aimed to assess bone microarchitecture in...
10.
Pereira R, Dagostin M, Caparbo V, Sales L, G Pasoto S, Silva C, et al.
Clinics (Sao Paulo)
. 2022 Dec;
78:100150.
PMID: 36529052
Objective: To evaluate inactivated CoronaVac prime vaccination, antibody decay, booster dose, and safety in ANCA-Associated Vasculitis (AAV) patients. Methods: Fifty-three AAV patients and 106 Controls (CG) received CoronaVac on days:...